02M1 Stock Overview
Provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Raffles Medical Group Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | S$0.59 |
52 Week High | S$0.71 |
52 Week Low | S$0.57 |
Beta | 0.53 |
11 Month Change | -0.84% |
3 Month Change | 0.85% |
1 Year Change | -16.31% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -39.11% |
Recent News & Updates
Recent updates
Shareholder Returns
02M1 | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0% | -1.9% | -1.8% |
1Y | -16.3% | 24.7% | 13.6% |
Return vs Industry: 02M1 underperformed the German Healthcare industry which returned 24.7% over the past year.
Return vs Market: 02M1 underperformed the German Market which returned 13.6% over the past year.
Price Volatility
02M1 volatility | |
---|---|
02M1 Average Weekly Movement | 5.5% |
Healthcare Industry Average Movement | 3.7% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.5% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 02M1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 02M1's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1976 | 2,900 | Choon Yong Loo | www.rafflesmedicalgroup.com |
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services segments. Its Raffles Hospital, a tertiary care hospital that offers a range of medical and surgical facilities include day angiography suites, operating theatres, delivery suites, intensive care unit, neonatal intensive care unit, radiology, clinical laboratory, and dental services.
Raffles Medical Group Ltd Fundamentals Summary
02M1 fundamental statistics | |
---|---|
Market cap | €1.15b |
Earnings (TTM) | €42.45m |
Revenue (TTM) | €489.63m |
27.1x
P/E Ratio2.4x
P/S RatioIs 02M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
02M1 income statement (TTM) | |
---|---|
Revenue | S$702.97m |
Cost of Revenue | S$392.09m |
Gross Profit | S$310.88m |
Other Expenses | S$249.94m |
Earnings | S$60.94m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.033 |
Gross Margin | 44.22% |
Net Profit Margin | 8.67% |
Debt/Equity Ratio | 7.2% |
How did 02M1 perform over the long term?
See historical performance and comparison